BU-NOT-SET

CONTACT US
Choosing the right container for your sterile drug product
  • Drug product
eBook: How a CDMO partner helps choose the right container for sterile drug products
eBook
Cell and virus banking in OV development and manufacturing
  • Biologics
Cell and virus banking
White paper
Overcoming technical transfer challenges in virotherapy manufacturing
  • Biologics
virotherapy
Insight
Flexibility in gene therapy: Adapting to the unique gene therapy demands
  • Biologics
gene therapy
eBook
Webinar: An optimised Plasmid DNA platform
  • Biologics
Plasmid DNA
Webinar
The future of oral solid dose formulations
  • Drug substance
  • Industry trends
oral solid dose
Insight
Trends and challenges to impact the OSD space in 2024 and beyond
  • Industry trends
OSD
Insight
Shaping pharma's carbon-reduced future
  • Sustainability
Sustainability
Insight
Focus on sustainability: Saving water in Bengaluru
  • Sustainability
Clouds
Insight
Case study
  • Drug product
Balancing solubility and extended release through science-led OSD development
Insight
  • Industry trends
Investing in capabilities for evolving customer needs
Insight
  • Drug product
  • Manufacturing
The human advantage
eBook
  • Drug product
  • Manufacturing
A connected approach to OSD development
Insight
  • Biologics
  • Manufacturing
Choosing a CDMO that can grow with a viral program
Insight
  • Biologics
  • Manufacturing
Turning oncolytic viruses into manufacturable cancer therapies
Case study
  • Drug product
  • Manufacturing
Science-led OSD reformulation
Case study
  • Development
  • Drug product
De-risking complex generic OSD development
Insight
  • Development
  • Drug product
Science-led OSD development